Clinical Trial Update: Phase II 5-Azacytidine Plus VPA Plus ATRA [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating a combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in myelodysplastic syndrome and acute myeloid leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• 5-Azacytidine (5-azacytidine)
• All-trans retinoic acid (ATRA) (all-trans retinoic acid)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelodysplastic Syndrome, Acute Myelogenous Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2011-07-11